EHang to Report Third Quarter 2022 Unaudited Financial Results on Friday, December 2, 2022
November 21, 2022 07:30 ET
|
EHang Holdings Limited
GUANGZHOU, China, Nov. 21, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang and HAECO Group Explore Partnership in Advanced Air Mobility
October 31, 2022 08:44 ET
|
EHang Holdings Limited
GUANGZHOU, China, Oct. 31, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform company,...
Freeline Announces September 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2022 16:01 ET
|
Freeline Therapeutics Holdings plc
LONDON, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on September 30, 2022, the Company granted five newly hired employees non-statutory...
Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease
October 04, 2022 07:00 ET
|
Freeline Therapeutics Holdings plc
LONDON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the first patient has been dosed in the second dose cohort of the Phase 1/2 MARVEL-1...
EHang Announces Progress in EH216-S Type Certification Process as It Enters into More In-Depth Review Phase
September 30, 2022 10:07 ET
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 30, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform...
Freeline Announces August 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2022 17:30 ET
|
Freeline Therapeutics Holdings plc
LONDON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on August 31, 2022, the Company granted two newly hired employees non-statutory...
EHang Reports Second Quarter 2022 Unaudited Financial Results
August 18, 2022 05:00 ET
|
EHang Holdings Limited
– Total Revenues Up 152.5% QoQ– High Quarterly Gross Margin of 67.1%– Indicative Facilities of RMB1 Billion by Agricultural Bank of China Guangzhou Branch– Increasing Deliveries in China and...
Freeline Reports Second Quarter 2022 Financial Results and Business Highlights
August 09, 2022 07:00 ET
|
Freeline Therapeutics Holdings plc
Six patients dosed in B-LIEVE trial of FLT180a in hemophilia B in four months and initial and emerging cohort one data reported, followed by NEJM publication of B-AMAZE long-term data Continued...
EHang to Report Second Quarter 2022 Unaudited Financial Results on Thursday, August 18, 2022
August 08, 2022 08:00 ET
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 08, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
Freeline Announces July 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2022 16:01 ET
|
Freeline Therapeutics Holdings plc
LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on July 29, 2022, the Company granted its newly hired Chief People Officer Nicole...